# Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients

> **NCT04300673** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Prostate Cancer
- Lymph Node Metastases

## Interventions

- **PROCEDURE:** Radio guided surgery (RGS) using Indium-labelled PSMA

## Key facts

- **NCT ID:** NCT04300673
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04300673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04300673, "Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04300673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*